BioTime, Inc.

BioTime, Inc., operating under the ticker LCTX, is a biotechnology company whose business model is fundamentally reliant on animal exploitation for product development. The company's core activities involve the research and development of therapies, a process that traditionally and currently requires extensive animal testing to meet regulatory standards for safety and efficacy. This exploitation is not ancillary but central to its operations, as indicated by standard license agreements that bind the company to comply with laws relevant to the "Exploitation" of its products, a term that encompasses the use of animal subjects.

While specific, recent enforcement actions against BioTime are not documented in the provided evidence, the company operates within an industry where such violations are prevalent. For instance, a major industry provider, Santa Cruz Biotechnology, was fined a historic $3.5 million by the U.S. government in 2016 for violations of the Animal Welfare Act. BioTime's business remains part of this same ecosystem, where animal use is a routine, scaled input. There is no public evidence that BioTime has adopted or committed to a robust alternative testing strategy that would materially reduce its reliance on animal models.